PM
TXG icon

Parametrica Management’s 10x Genomics TXG Stock Holding History

Parametrica Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15,300
Closed -$631K – 37
2023
Q3 		$631K Buy
15,300
+500
+3% +$26K 1.06% 24
2023
Q2 		$826K Buy
14,800
+439
+3% +$23.8K 1.59% 19
2023
Q1 		$801K Buy
+14,361
New +$671K 1.45% 20
2022
Q4 		– Sell
-34,848
Closed -$992K – 78
2022
Q3 		$992K Buy
34,848
+21,187
+155% +$807K 2.03% 12
2022
Q2 		$622K Buy
+13,661
New +$709K 0.68% 34
2021
Q2 		– Sell
-2,410
Closed -$405K – 180
2021
Q1 		$405K Buy
+2,410
New +$416K 0.19% 89

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parametrica Management's TXG Position: Q4 2023 in Review

Parametrica Management sold out of 10x Genomics (TXG) in Q4 2023, closing a stake of 15,300 shares — an estimated $631K sold.

Parametrica Management first reported a position in TXG in Q1 2021 and held it in 6 quarters. The position peaked at $992K in Q3 2022. 275 funds tracked by Wall St. Rank hold TXG as of Q4 2023.

  • Parametrica Management reported no remaining 10x Genomics position as of Q4 2023 after selling out during the quarter.
  • Parametrica Management sold 15,300 10x Genomics shares in Q4 2023, an estimated $631K.
  • Parametrica Management first reported a position in 10x Genomics in Q1 2021 and held it in 6 quarters.
  • Parametrica Management's 10x Genomics position peaked at $992K in Q3 2022.
  • 275 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2023.

Based on Parametrica Management's 13F filing for Q4 2023, filed 2 Feb 2024.